✓ Free · Updated February 2026 · No signup required

Palantir (PLTR) Analyst Rating Tracker & Price Target Consensus 2026

See What Wall Street Really Thinks About Palantir Right Now

Wall Street's view on Palantir Technologies (PLTR) has undergone a dramatic transformation. After years of skepticism, major analysts including Morgan Stanley, Goldman Sachs, and others have significantly upgraded their ratings following the company's expansion into commercial markets, achievement of GAAP profitability in Q3 2024, and inclusion in the S&P 500. But analyst ratings constantly change—and you need to know what the consensus actually is right now.

This tracker aggregates current analyst ratings, price targets, and rating change history from the major Wall Street firms covering Palantir. See the distribution of Buy/Hold/Sell ratings, the consensus price target, and understand which analysts are most bullish (or bearish) on PLTR's future. Track rating changes over time and understand the catalysts behind the upgrades.

Whether you're a current shareholder, considering buying Palantir, or just interested in understanding analyst sentiment, this tool gives you the real-time consensus data you need to make informed decisions.

Current Stock Price 📈
$42.75
Consensus Price Target (12-month) 📈
$58.50
Buy Ratings 📈
18
Hold Ratings ➡️
9
Sell Ratings 📉
2
Analyst Consensus 📈
Overweight
Average Price Target Upside 📈
36.8%
Commercial Revenue % 📈
38%
Government Revenue % 📉
62%
Last Rating Change ➡️
Jan 28, 2026

What Changed? The 2024-2026 Analyst Upgrade Wave

For years, Palantir was one of Wall Street's most controversial stocks. Multiple major analysts maintained 'Underweight' or 'Sell' ratings, citing concerns about government revenue dependency, high valuation multiples, and questions about sustainable profitability. Then, starting in late 2024, the narrative shifted dramatically.

The Key Catalyst: Palantir achieved GAAP profitability in Q3 2024—their first profitable quarter on a GAAP basis—while maintaining 27% year-over-year revenue growth. Commercial revenue accelerated significantly, growing to represent 38% of total revenue (up from ~20% in 2023), reducing the company's historical over-reliance on government contracts. CEO Alex Karp's emphasis on AI integration into Gotham and Apollo platforms resonated with investors and analysts alike.

Morgan Stanley upgraded from Underweight to Equal-Weight. Goldman Sachs and several other Tier-1 firms moved from Hold to Buy positions. The S&P 500 inclusion in September 2024 further validated the company's trajectory, attracting institutional capital and analyst coverage. As of February 2026, the consensus has shifted decisively bullish, with 18 Buy/Overweight ratings versus only 2 Sell/Underweight ratings.

Understanding Analyst Price Targets & Upside Potential

The consensus 12-month price target of $58.50 (as of February 2026) represents 36.8% upside from current levels. But price targets vary significantly across analysts, reflecting different views on growth rates, profit margins, and terminal valuations. Bullish analysts see a clear path to $70+ as commercial revenue grows and government business stabilizes at scale. Conservative analysts stay in the $45-50 range, citing valuation concerns even after the recent gains.

How to Use Price Targets: Consensus targets are useful directional indicators, but individual analyst targets often reveal important splits. Tier-1 investment banks' targets (Goldman, Morgan Stanley, JPMorgan) typically carry more weight due to their research resources and market influence. Wide ranges between analyst targets suggest genuine uncertainty—which can mean opportunity or risk depending on your time horizon.

Remember: price targets are 12-month estimates and should not be treated as guarantees. They're updated quarterly or when major catalysts emerge, so check back regularly to see if targets have changed due to earnings beats, product announcements, or macro shifts.

Government vs. Commercial Revenue: Why Analysts Got More Bullish

The single biggest reason for the analyst upgrade wave was Palantir's shift away from government revenue dependency. Historically, government contracts represented 70%+ of revenue, which created two problems: (1) limited growth potential due to budget constraints and procurement cycles, and (2) valuation discounts from analysts who viewed Palantir as a 'government services company' rather than a tech/software platform.

The improvement in commercial revenue—now at 38% of total revenue—demonstrates that Palantir's core technology (Gotham and Apollo) has viable commercial applications. This changes the growth narrative. Instead of a government contractor growing at government-spending rates, analysts can model Palantir as a software platform with 20%+ commercial growth rates and potential for higher profit margins.

Key Metrics Analysts Track: Year-over-year commercial revenue growth rate (currently ~40%+ YoY), commercial customer count, average contract value (ACV) expansion, and government revenue stability. As commercial becomes an increasingly large percentage of the mix, analyst models project higher earnings growth and justify higher valuation multiples. This is why government revenue declining as a percentage of total revenue is actually a positive sign to analysts.

How to Interpret Rating Changes & Stay Updated

Analyst ratings change for specific reasons. When you see a rating change in the tracker, look for the catalyst: Was there an earnings beat? A new product announcement? A macro shift in AI spending? A guidance raise? Understanding the 'why' behind a rating change matters more than the rating itself.

Rating Volatility Patterns: Palantir's stock is particularly volatile around quarterly earnings (typically late April, late July, late October, and late January). Expect analyst rating changes in the 2-3 weeks following earnings releases. Similarly, any major AI product launch, commercial customer win, or management guidance change triggers reviews from multiple analysts simultaneously.

Use the timeframe filter in this tracker to see recent momentum. If most Buy/Overweight upgrades happened in the past 3 months, it suggests fresh bullish sentiment. If upgrades are concentrated from 12+ months ago, the thesis may be partially priced in already. Monitor this tracker weekly if you're actively managing a PLTR position.

Frequently Asked Questions

Quick answers to common questions

Is Palantir a buy based on analyst ratings?
As of February 2026, analyst consensus is 'Overweight/Buy' with 18 of 29 analysts rating it a Buy. However, analyst ratings are not personal investment advice. Consider your own risk tolerance, time horizon, and whether 36%+ upside potential justifies holding a stock with government/commercial transition risks. A 12-month price target assumes conditions remain favorable; geopolitical shifts, competitive threats, or macro slowdowns could impact outcomes.
Why did analysts upgrade Palantir so much in 2024-2025?
Three factors: (1) GAAP profitability achieved in Q3 2024, ending 'not profitable' criticism, (2) Commercial revenue acceleration to 38% of total revenue, reducing government dependency, and (3) S&P 500 inclusion, which validated the company's scale and attracted institutional capital. CEO Alex Karp's emphasis on AI also aligned with broader industry tailwinds.
What's the difference between price targets and current price?
Price targets are analyst estimates of where a stock should trade in 12 months based on projected earnings, growth rates, and valuation multiples. Current price reflects where it trades today. The difference is 'upside' or 'downside' potential. A 12-month target of $58.50 on a $42.75 current price implies 36.8% upside if that analyst is correct.
Why do analysts have different price targets?
Different analysts have different assumptions about revenue growth rates, operating margins, terminal growth rates, and appropriate valuation multiples (P/E ratios). Bullish analysts assume faster commercial growth and higher margins; conservative analysts are more cautious. Wide ranges suggest genuine uncertainty in the market.
When should I check this tracker?
Check after quarterly earnings releases (typically late April, July, October, January), when major product announcements occur, or monthly if actively trading PLTR. Analyst ratings often change within 2-3 weeks of significant catalysts. If rating changes cluster recently, it signals fresh momentum or concern.
📊
Share Your Results

See how your friends compare

𝕏 f in